Sorry, this entry is only available in Ukrainian.
SCHOTT Pharma представила новий картридж для чутливих біологічних препаратів
Вас может заинтересовать:
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
WEB only
On 1 October 2023, Kevin Stembridge has been appointed to Chief Product Officer (CPO) / Executive Vice President (EVP) for the Software Business Unit in the Körber Business Area Pharma.…
